Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients

Name: Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients
Published: 2003
License: Public Domain

Catholic University of the Sacred Heart · 2003

ClinicalTrials.gov · Datasets · License: Public Domain · 2003

Open Source ↗

progression-free-survival quality-of-life toxicity

ovarian neoplasms, carboplatin plus celecoxib, pre-treated recurrent ovarian cancer patients, the antitumor activity and potential adverse effects, tumor response rate, toxicity, progression free survival, duration of response, quality of life, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients

Related documents